Ekso Bionics Announces Transformative Reverse Merger with Applied Digital Cloud, Leading to Extreme Shareholder Dilution and Control Shift

summarizeSummary

Ekso Bionics is undergoing a reverse merger with Applied Digital Cloud Corporation, resulting in extreme dilution for current shareholders and a change of control, as revealed by the definitive agreement and poor preliminary Q4 2025 financial results.

check_boxKey Events · M&A and Partnerships · EKSO

• Transformative Business Combination

  Ekso Bionics is entering into a Contribution and Exchange Agreement to combine with Applied Digital Cloud Corporation, a subsidiary of Applied Digital Corporation. Ekso will become a wholly-owned subsidiary of Cloud and change its name to ChronoScale Corporation.

• Extreme Shareholder Dilution

  The Contributor will receive 138,216,820 newly issued shares of Ekso common stock, resulting in the Contributor owning approximately 97% of the combined company's outstanding equity, leading to extreme dilution for existing shareholders. This follows the DEFA14A filing on the same day which announced this extreme dilution.

• Change of Control and Governance Shift

  The transaction constitutes a change of control, with the APLD Investor gaining significant governance rights, including the ability to designate four of seven directors and consent rights over key corporate actions if they own at least 30% of voting securities. Authorized common stock will increase to 290,000,000 shares.

• New Equity Incentive Plan

  A new 2026 Omnibus Equity Incentive Plan has been approved, authorizing the issuance of 22,500,000 shares of common stock, which will be highly dilutive relative to the current outstanding share count.

auto_awesomeAnalysis · EKSO · Technology

This 8-K details a highly significant, thesis-altering business combination where Ekso Bionics will merge with Applied Digital Cloud Corporation (a subsidiary of Applied Digital Corporation), effectively becoming a subsidiary itself and changing its name to ChronoScale Corporation. The issuance of 138,216,820 new shares to the Contributor, who will own approximately 97% of the combined company, represents extreme dilution for existing shareholders. This transaction fundamentally shifts control and ownership. The concurrent preliminary Q4 2025 financial results, showing a substantial revenue decline and increased cash burn, underscore the company's distressed financial position and the necessity of such a dilutive capital event. The new equity incentive plan authorizing 22,500,000 shares and the significant changes to corporate governance further solidify the complete transformation of the company.